A focused, high-yield clinical update exploring modern strategies in adult preventive care, obesity pharmacotherapy, diabetes management, and resistant hypertension.

This one-day conference delivers concise, practical education for clinicians at the intersection of preventive and cardiometabolic care. Across four expert-guided hours, learners will explore the latest evidence in cancer screening, obesity treatment, GLP-1–based therapies, and complex hypertension. Designed for real-world application, the sessions emphasize actionable guidance for today’s primary care and internal medicine practitioners.

Day 1

This one-hour session presents a structured approach to preventive care in adults, including screening, immunization, behavioral counseling, and special considerations in patients with comorbidities. The curriculum aligns with current USPSTF recommendations and addresses implementation in primary care.

Comprehensive Preventive Care for Adults

This module introduces the foundational concepts of preventive care in adults, including the goals, levels of prevention, USPSTF grading system, and how to individualize care based on patient factors.

Principles and Framework of Preventive Care

This session provides an evidence-based review of screening recommendations for common cancers (breast, cervical, colorectal, prostate) and cardiovascular risk factors, including hypertension and lipid disorders.

Cancer and Cardiovascular Screening in Adults

This module reviews recommended adult immunizations and behavioral counseling topics including tobacco cessation, alcohol misuse, diet, and physical activity, with attention to risk stratification and timing.

Immunization and Behavioral Counseling in Preventive Care

This final module focuses on tailoring preventive strategies for adults with chronic diseases, addressing issues such as life expectancy, polypharmacy, and the diminishing benefit of certain screenings.

Preventive Care in Adults with Chronic Conditions

Break

This session provides a comprehensive update on the drug treatment of obesity in adults, including selection criteria, medication comparisons, and strategies for ongoing patient management. Emphasis is placed on evidence-based prescribing and personalized treatment planning.

Pharmacologic Management of Obesity in Adults

This module covers the clinical indications for initiating drug therapy in adult patients with obesity, including BMI thresholds, comorbid conditions, and the role of lifestyle interventions prior to medication use.

Identifying Candidates for Obesity Pharmacotherapy

This session introduces the FDA-approved medications for obesity treatment, organized by mechanism of action. It includes discussion of GLP-1 receptor agonists, combination drugs, and appetite suppressants.

Overview of Anti-Obesity Medications

This module explores the relative efficacy of anti-obesity medications and how to choose the most appropriate agent based on patient profiles, expected weight loss, tolerability, and cost.

Comparative Efficacy and Selection of Obesity Medications

This final module provides a framework for follow-up, including evaluation of response, duration of therapy, switching strategies, and when to discontinue medications.

Monitoring and Managing Patients on Obesity Drug Therapy

This one-hour CME session explores the mechanisms, clinical indications, benefits, and risks of GLP-1 receptor agonists for the treatment of type 2 diabetes. The program includes pharmacologic comparisons, cardiovascular outcomes, and adverse effect management.

GLP-1–Based Therapies for Type 2 Diabetes

This module introduces the biological functions of endogenous GLP-1 and explains how GLP-1 receptor agonists modulate glucose metabolism, appetite, and insulin secretion.

Mechanisms and Physiologic Effects of GLP-1 Therapies

This session reviews the primary and expanded indications for GLP-1 therapy in type 2 diabetes, including weight reduction and cardiovascular protection in high-risk patients.

Clinical Indications and Cardiometabolic Benefits

This module provides a head-to-head comparison of available GLP-1 receptor agonists, focusing on glycemic efficacy, dosing schedules, injectable versus oral formulations, and combination therapies.

Comparing GLP-1 Receptor Agonists: Efficacy and Dosing

This final module outlines strategies for managing common adverse effects of GLP-1 therapy, including gastrointestinal intolerance and rare risks, and provides guidance on initiating or switching therapy.

Managing Side Effects and Patient Selection

This session explores the multifactorial contributors to resistant hypertension and offers a systems-based approach to its evaluation and management. Modules address pharmacologic strategies, secondary causes like primary aldosteronism and sleep apnea, and management considerations in chronic kidney disease.

Resistant Hypertension: A Systems-Based Approach to a Complex Challenge

Evidence-based evaluation and treatment pathway for resistant hypertension, including medication strategies, lifestyle modification, and team-based care.

Resistant Hypertension: Practical Update for Busy Clinicians

A focused review of screening, diagnostic confirmation, and treatment pathways for primary aldosteronism as a secondary cause of resistant hypertension.

Primary Aldosteronism: The Overlooked Driver of Resistant Hypertension

Explores the relationship between obstructive sleep apnea and resistant hypertension, emphasizing screening tools, diagnostics, and the role of CPAP therapy.

Obstructive Sleep Apnea and Hypertension: Unmasking the Nocturnal Link

Outlines optimal antihypertensive approaches in patients with chronic kidney disease, including agent selection, monitoring, and referral timing.

Navigating Hypertension in Chronic Kidney Disease: A Therapeutic Balancing Act

End of Day

A global forum to explore advances and research in women’s health, reproductive science, and fertility.

The World Congress on Women’s Health, Reproduction and Fertility brings together global experts and practitioners to explore the latest advancements, share clinical practices, and foster collaborations. This summit is a vital opportunity to connect research with real-world outcomes in reproductive and women's health sciences.

Recent innovations in hormonal regulation and disorders affecting reproductive function.

Advances in Reproductive Endocrinology

Exploring methods to preserve fertility in cancer patients and aging populations.

Fertility Preservation Techniques

Guidelines and innovations in hormonal treatments for reproductive health issues.

Hormonal Therapies in Gynecology

A review of assisted reproductive technologies with an ethical perspective.

IVF Technology and Ethics

Strategies to improve maternal outcomes globally where access is limited.

Maternal Health in Low-Resource Settings

New understandings and treatments for polycystic ovary syndrome.

PCOS: Latest Research

Tailored reproductive care strategies for adolescent populations.

Adolescent Reproductive Health

Clinical innovations improving fetal outcomes during pregnancy.

Breakthroughs in Fetal Medicine

Evidence-based approaches to managing menopause symptoms.

Menopause Management Strategies

New diagnostic and treatment strategies for endometriosis.

Endometriosis: Clinical Advances

How the immune system impacts fertility and pregnancy outcomes.

Reproductive Immunology

Current practices in prenatal genetic testing and counseling.

Genetic Screening in Pregnancy

The impact of pollutants and chemicals on reproductive health.

Fertility and Environmental Toxins

Best practices in sexual health communication and education.

Sexual Health and Education

Cultural and global health factors shaping women’s care.

Washington, DC

Conferences

Clinical Frontiers in Hypertension, Obesity, and Preventive Medicine

World Congress on Women's Health, Reproduction and Fertility